Expanded access program (EAP) to investigational drugs.

被引：0
|
作者：
Talarico, L [1 ]
Pazdur, R [1 ]
机构：
[1] US FDA, Rockville, MD 20857 USA
来源：
JOURNAL OF CLINICAL ONCOLOGY | 2004年 / 22卷 / 14期
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
6001
引用
收藏
页码：519S / 519S
页数：1
相关论文
共 50 条
  • [31] Do Physicians Have a Duty to Discuss Expanded Access to Investigational Drugs with their Patients? A Normative Analysis
    Vermeulen, Stefan F.
    Hordijk, Marjolijn
    Visser, Ruben J.
    Bunnik, Eline M.
    JOURNAL OF LAW MEDICINE & ETHICS, 2023, 51 (01): : 172 - 180
  • [32] Factors of feasibility: an interview study of physicians’ experiences of expanded access to investigational drugs in three countries
    Stefan F. Vermeulen
    Marjolijn Hordijk
    Nikkie Aarts
    Eline M. Bunnik
    Humanities and Social Sciences Communications, 8
  • [33] EXPANDED-ACCESS PROGRAM (EAP) OF SUNITINIB IN 458 PATIENTS WITH METASTATIC RENAL CELL CARCINOMA
    Sternberg, C. N.
    Porta, C.
    Bracarda, S.
    Carteni, G.
    Lo Re, G.
    Ruggeri, E. M.
    Conte, P.
    Monfardini, S.
    Gasparini, G.
    Ciuffreda, L.
    ANNALS OF ONCOLOGY, 2008, 19 : 194 - 194
  • [34] The changing landscape of expanded access to investigational drugs for patients with unmet medical needs: ethical implications
    Eline M. Bunnik
    Nikkie Aarts
    Suzanne van de Vathorst
    Journal of Pharmaceutical Policy and Practice, 10 (1)
  • [35] EXPANDED ACCESS PROGRAM (EAP) FOR LENALIDOMIDE PLUS DEXAMETHASONE IN PATIENTS WITH RELAPSED OR REFRACTORY MULTIPLE MYELOMA
    Palumbo, A.
    Gay, F.
    Buda, G.
    Guglielmelli, T.
    Perrone, G.
    Corradini, P.
    Benedetti, F.
    Offidani, M.
    Rossi, D.
    Gozzetti, A.
    Catalano, L.
    Canepa, L.
    Di Raimondo, F.
    Patriarca, F.
    Petrucci, M. T.
    Di Renzo, N.
    Galli, M.
    Cavallo, F.
    Bringhen, S.
    Boccadoro, M.
    HAEMATOLOGICA-THE HEMATOLOGY JOURNAL, 2008, 93 : 257 - 257
  • [36] Teprotumumab for the Treatment of Thyroid Eye Disease: Clinical Experience from Expanded Access Program (EAP)
    Wang, Yao
    Mester, Tunde
    Ugradar, Shoaib
    Douglas, Raymond
    INVESTIGATIVE OPHTHALMOLOGY & VISUAL SCIENCE, 2021, 62 (08)
  • [37] Little to lose and no other options: Ethical issues in efforts to facilitate expanded access to investigational drugs
    Bunnik, Eline M.
    Aarts, Nikkie
    van de Vathorst, Suzanne
    HEALTH POLICY, 2018, 122 (09) : 977 - 983
  • [38] Factors of feasibility: an interview study of physicians' experiences of expanded access to investigational drugs in three countries
    Vermeulen, Stefan F.
    Hordijk, Marjolijn
    Aarts, Nikkie
    Bunnik, Eline M.
    HUMANITIES & SOCIAL SCIENCES COMMUNICATIONS, 2021, 8 (01):
  • [39] Radium-223 dichloride (Ra-223) in US expanded access program (EAP).
    Vogelzang, Nicholas J.
    Fernandez, Daniel Celestino
    Morris, Michael J.
    Iagaru, Andrei
    Brown, Alan
    Almeida, Fabio
    Sweeney, Christopher
    Smith, Matthew Raymond
    Dicker, Adam
    Wong, Yu-Ning
    Shore, Neal D.
    Bangerter, Keith
    Petrenciuc, Oana
    Sartor, A. Oliver
    JOURNAL OF CLINICAL ONCOLOGY, 2015, 33 (07)
  • [40] ACCESS TO INVESTIGATIONAL DRUGS FOR TREATMENT PURPOSES
    NIGHTINGALE, SL
    KIMBROUGH, CA
    RHEINSTEIN, PH
    AMERICAN FAMILY PHYSICIAN, 1994, 50 (04) : 845 - 847
12345